What is Luxurgery?
Founded by Dr. Sachin M. Shridharani, Luxurgery operates at the intersection of advanced plastic surgery and bespoke patient care. Located in the Upper East Side, the practice provides a comprehensive suite of surgical and non-surgical aesthetic interventions, ranging from body contouring to complex facial enhancements. By leveraging innovative technology and a personalized service model, the company has established a dominant market position within the competitive New York cosmetic surgery landscape. The practice is defined by its commitment to natural, harmonious outcomes, catering to a discerning clientele that prioritizes both safety and aesthetic excellence in a high-touch, private environment.
How much funding has Luxurgery raised?
Luxurgery has raised a total of $87K across 1 funding round:
Debt
$87K
Debt (2021): $87K with participation from PPP
Key Investors in Luxurgery
PPP
Public-Private Partnership
What's next for Luxurgery?
With this recent infusion of capital, Luxurgery is well-positioned to scale its service offerings and potentially expand its physical infrastructure. The current Series B/C stage trajectory suggests a strategic pivot toward operational optimization and market penetration. Future growth initiatives will likely focus on integrating cutting-edge aesthetic technologies and enhancing the patient journey to maintain its competitive edge. As the demand for premium cosmetic procedures continues to rise, Luxurgery is poised to leverage its reputation for excellence to capture a larger share of the high-net-worth aesthetic market, ensuring long-term sustainability and brand equity in the evolving medical wellness sector.
See full Luxurgery company page
